GOSS · Forms 3, 4, 5
Insider trades at Gossamer Bio, Inc.
No open-market insider buys or sells at Gossamer Bio, Inc. in the last 90 days; 13 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Gossamer Bio, Inc. (GOSS) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Sandra Milligan | Director | Options or other derivatives | Form 4 | ||||
| Thomas O Daniel | Director | Options or other derivatives | Form 4 | ||||
| Gregory Austin Ciongoli | Director | Options or other derivatives | Form 4 | ||||
| Skye Drynan | Director | Options or other derivatives | Form 4 | ||||
| John D Quisel | Director | Options or other derivatives | Form 4 | ||||
| Russell J. Cox | Director | Options or other derivatives | Form 4 | ||||
| Steven D Nathan | Director | Options or other derivatives | Form 4 | ||||
| Gregory Austin Ciongoli | Director | Became an insider (Form 3) | Form 3 | ||||
| Waage Christian | EVP, Tech Ops and Admin | Options or other derivatives | Form 4 | ||||
| Caryn Peterson | Chief Development Officer | Options or other derivatives | Form 4 | ||||
| Robert Paul Smith JR | Chief Commercial Officer | Options or other derivatives | Form 4 | ||||
| Bryan Giraudo | COO/CFO | Options or other derivatives | Form 4 | ||||
| Faheem Hasnain | President & CEO | Options or other derivatives | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.